ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT
Report
- Report Number
- 3005094123-2026-00192
- Event Type
- Malfunction
- Date Received
- April 27, 2026
- Date of Event
- April 15, 2026
- Report Date
- April 27, 2026
- Manufacturer
- ABBOTT IRELAND DIAGNOSTICS DIVISION
- Product Code
- MMI
- UDI-DI
- 00380740160630
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- EI
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT, LIST NUMBER 08P13 THAT HAS A SIMILAR PRODUCT DISTRIBUTED IN THE US, LIST NUMBER 04Z21, ALINITY I STAT HIGH SENSITIVITY TROPONIN-I, WITH 510K/PMA/BLA NUMBER K202525. SECTION E: E1 - ADDRESS 1: COMPLETE ADDRESS INFORMATION: DEPARTMENT OF CLINICAL BIOCHEMISTRY AND DIAGNOSTIC ENDOCRINOLOGY AN EVALUATION IS IN PROCESS. A FOLLOW-UP REPORT WILL BE SUBMITTED WHEN THE EVALUATION IS COMPLETE.
A CONFERENCE ABSTRACT BY CULLEN, M.R., AND LEE, G.R., ¿EVALUATION OF FREE THYROXINE AND HIGH SENSITIVITY CARDIAC TROPONIN DUPLICATE TESTING,¿ CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2026; 64(4): EA78. DOI: 10.1515/CCLM-2026-0148, DESCRIBES THE USE OF ROUTINE DUPLICATE TESTING AS A RISK MANAGEMENT STRATEGY TO DETECT ANALYTICAL ERRORS IN ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN I RESULTS GENERATED BY THE ALINITY I PROCESSING MODULES. DUPLICATE TESTING WAS PERFORMED FOR ALL ELEVATED ALINITY I STAT HIGH SENSITIVE TROPONIN I RESULTS >7 NG/L. ANALYTICAL ERROR WAS DETECTED IN 112 (B)(4) OF 13,772 DUPLICATE MEASUREMENTS, WITH CRITICAL ERRORS (THOSE CROSSING SEX SPECIFIC (B)(4) PERCENTILE DECISION LIMITS) OCCURRING IN ONLY 5 (0.04%) OF CASES. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 532776 | ALINITY I STAT HIGH SENSITIVE TROPONIN-I REAGENT KIT | IMMUNOASSAY METHOD, TROPONIN SUBUNIT | MMI | ABBOTT IRELAND DIAGNOSTICS DIVISION | 00380740160630 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |